Mitotic centromere associated kinesin (MCAK) is a kinesin related protein with the ability to stimulate microtubule depolymerization. It is found at spindle poles, where it may be involved in poleward microtubule flux, and at kinetochores and centromeres where it plays a role in correcting chromosome alignment errors. Its microtubule depolymerase activity and recruitment to centromeres is regulated by phosphorylation, but little is known about how MCAK is maintained at appropriate levels. We previously reported that MCAK accumulates during the cell cycle and is then degraded during mitosis. Using proteomic analysis, we have now identified a new phosphorylation site on MCAK that is responsible for its degradation. Mutation of the site to prevent phosphorylation prolonged the stability of the protein beyond the metaphase to anaphase transition and into the subsequent cell cycle whereas a phosphomimetic mutation accelerated degradation. Unexpectedly, the mutation that prevented phosphorylation also inhibited the removal of MCAK from centromeres causing it to remain attached throughout the cell cycle. Even low expression of phosphorylation-resistant MCAK delayed mitosis and interfered with cell division. Mitotic defects were also observed by overexpressing a green fluorescent proteintagged version of wild-type MCAK that similarly escaped degradation and accumulated to toxic levels, but did not remain associated with kinetochores during interphase. The results demonstrate that degradation is an important mechanism for controlling the activity of MCAK. V C 2012 Wiley Periodicals, Inc
Introduction

K
inesin related proteins comprise a large superfamily of ATP driven microtubule motor proteins characterized by highly homologous microtubule binding motor domains but a diverse array of structures and functions [Miki et al., 2005] . Many members of this family are designed to bind cargo and translocate it through the cell along microtubule tracks, but others play more specific roles in mitotic spindle assembly and chromosome segregation [Civelekoglu-Scholey and Scholey, 2010] . Members of one particularly interesting subclass of kinesin related proteins have an internal motor domain and have therefore been called Kin I kinesins, but a more recent classification system assigns these proteins to the kinesin-13 family [Lawrence et al., 2004] . One of the first members of the kinesin-13 family to be identified was mitotic centromere associated kinesin (MCAK) or Kif2c. Kin 13 proteins such as MCAK have been shown to bind microtubules in vitro, diffuse to the microtubule ends, and stimulate disassembly [Desai et al., 1999; Helenius et al., 2006] . This activity is believed to be important for the ability of MCAK and MCAK-like proteins to correct inappropriate microtubule attachments at kinetochores, thereby ensuring the faithful segregation of chromosomes during mitosis .
MCAK contains several phosphorylation sites that have been shown to be important for controlling the location and activity of the protein [Ems-McClung and Walczak, 2010] . In addition, recent evidence indicates that protein degradation plays an important role in regulating MCAK function. Mammalian MCAK and a homolog in Leishmania major have been shown to accumulate as the cell cycle progresses, reaching a maximum concentration in mitosis [Dubessay et al., 2006; Ganguly et al., 2008] . Once the mitotic checkpoint is satisfied by the alignment of chromosomes at the metaphase plate, the protein undergoes proteasomal degradation before being synthesized again during the next cell cycle [Ganguly et al., 2008] . It was previously reported that mitotic MCAK forms two bands on sodium dodecyl sulfate (SDS) gels and that the slower migrating band results from a mitosis-specific phosphorylation [Ganguly et al., 2008; Shimo et al., 2008] . We now report the identification of this phosphorylation site and demonstrate that it regulates MCAK stability and persistence at kinetochores.
Results
Identification of Novel Phosphorylation Sites
SDS gel analysis has shown that MCAK from mitotic, but not interphase cells migrates as two distinct bands and that the upper (slower migrating) band reverts to normal mobility when the extracts are treated with alkaline phosphatase [Ganguly et al., 2008; Shimo et al., 2008] . It was further found that the upper band did not arise from phosphorylation by Aurora B, a kinase that is known to phosphorylate MCAK at multiple sites [Ganguly et al., 2008] . Finally, it was reported that the upper band was preferentially lost at metaphase, but it could be stabilized by treating the cells with the proteasomal inhibitor MG-132, thus implying that phosphorylation was a signal for MCAK degradation.
To identify the phosphorylation sites responsible for degradation, a mitotic cell lysate from CHO cells expressing FLAG-tagged human MCAK was prepared. A FLAG antibody immobilized on protein-G agarose beads was then added and proteins in the immunoprecipitate were resolved by SDS gel electrophoresis. Phosphate containing peptides from the upper and lower MCAK bands were enriched by TiO 2 affinity chromatography and analyzed by MS. This approach led to the identification of two phosphorylated amino acids, S166 and S628, that were present in the upper band, but not in the lower band. The MS/MS spectrum of the tryptic peptide containing S628 is shown in Fig. 1 and its location relative to the domain structure of MCAK is shown in Supporting Information Fig. S1 .
Mutation of S628 and S629 Alters the Electrophoretic Mobility of MCAK
To determine whether either of the identified phosphorylation sites was responsible for altering the electrophoretic mobility of MCAK, WT as well as S166A and S628A mutants of Flag-MCAK were transfected into CHO cells using a tetracycline regulated expression vector, the cells were synchronized in mitosis, and lysates were compared for the presence or absence of the upper MCAK band (Fig. 2) . As previously observed [Ganguly et al., 2008] , WT FLAG-MCAK displayed approximately equal amounts of the upper and lower bands. Mutant S166A also had similar upper and lower band intensities ( Fig.  2A ) but the S628A mutant exhibited a significant reduction in the intensity of the upper band (Fig. 2B) . The results suggested that phosphorylation of S628 was responsible, at least in part, for the altered mobility of MCAK on SDS gel electrophoresis.
Because there is a second serine at residue 629, we considered the possibility that preventing S628 phosphorylation might cause the kinase to phosphorylate S629, albeit at a lower efficiency. We tested this possibility by creating the S628A/S629A double mutant. Analysis of mitotic lysates revealed that the double mutant had no detectable upper band (Fig. 2C) , demonstrating that phosphorylation of S628 or S629 was necessary to retard the mobility of MCAK on SDS gels. This conclusion was further strengthened by creating the S628D/S629D phosphomimetic mutations which caused the loss of the lower MCAK band (Fig. 2C ).
Mutation of S628 and S629 Alters the Stability of MCAK
In our previous study it was found that phosphorylated, slowly migrating MCAK disappeared more quickly than Fig. 1 . MS/MS fragmentation of the peptide containing S628. The tryptic peptide containing S628 (followed by an asterisk) was fragmented and analyzed by mass spectrometry. The fragmentation data indicated phosphorylation of S628. n 304 the faster migrating MCAK as the cells progressed through mitosis, thus implying that the phosphorylated form of the protein might be preferentially degraded [Ganguly et al., 2008] . To determine whether phosphorylation of S628 triggers degradation, we analyzed the stability of mutant and WT Flag-MCAK in transfected CHO cells using a ''pulse-chase'' experiment. FLAG-MCAK production was first induced by incubating the cells overnight without tetracycline, and the antibiotic was then added back to halt further transcription of the cDNA. Cells were sampled at various times following tetracycline addition and analyzed by western blots to determine how quickly the FLAG-MCAK protein disappeared. The results (Fig.  3 ) demonstrated that WT FLAG-MCAK was progressively depleted and largely lost by 12 h following tetracycline addition as previously reported [Ganguly et al., 2008] . The S628D/S629D double mutant designed to mimic the phosphorylated protein appeared to be even less stable and was barely detectable after only 8 h (Fig. 3A ). In contrast, the S628A mutant protein disappeared at a slower rate than WT such that it was still detectable at 12 h, and the S628A/S629A double mutant was even more highly stabilized and prominent at 12 h.
The results were plotted in Fig. 3B and gave relative half lives for the proteins of 4.5, 5.8, 7.4, and 15 h for the DD, WT, A, and AA versions of FLAG-MCAK respectively. However, it should be noted that these numbers likely underestimate the stability of the FLAG-MCAK and of the AA mutant in particular because the amount of protein was estimated relative to actin whose synthesis was not halted by the addition of tetracycline. If one factors in the doubling time for CHO cells, this would produce a 50% decrease in the FLAG-MCAK to actin ratio in 12 h by dilution alone (i.e., by a doubling of the amount of actin). This point is further strengthened by an experiment in which FLAG-MCAK was allowed to accumulate and compared to actin in cells that were induced by tetracycline removal. In this case, the FLAG-MCAK to actin ratio remained relatively constant over a 48 h period for the WT and DD proteins that were subject to degradation; but the ratio progressively increased for the degradation-resistant AA mutant (Supporting Information Fig. S2 ). Based on these observations, we conclude that there is very little degradation of the AA mutant. Because MCAK degradation is normally triggered at the metaphase to anaphase transition [Ganguly et al., 2008] , we reasoned that the increased stability of the AA mutant could be due to blockage of the cells in prometaphase. To test this possibility, cells induced to express WT or mutant FLAG-MCAK were synchronized by successive thymidine and nocodazole blocks followed by shaking off mitotic cells and reversing the nocodazole block. The cells were then sampled at various times to determine their cell cycle stage. Most of the shake-off cells transfected with WT FLAG-MCAK ( Fig. 4A ) were initially in prometaphase and showed a steady progression through metaphase, anaphase, and telophase that resulted in an accumulation of G1-phase cells within 45 min. Cells transfected with the AA mutant ( Fig. 4B) showed a similar progression, but the amount of time required to reach G1 phase was approximately twofold longer. The slower mitotic transit of cells producing the AA mutant protein appeared to result from a delay in the time required for cells to progress beyond prometaphase.
The twofold increase in time needed to complete mitosis was insufficient to account for the greatly increased stability of the 628A/629A FLAG-MCAK, but it did indicate that expression of the mutant protein interfered with normal mitotic progression. This toxicity of the AA mutant was further supported by the fact that, in contrast to the WT FLAG-MCAK, stable clones capable of expressing the mutant cDNA were difficult to isolate and tended to quickly lose expression even when the cells were maintained in tetracycline. Moreover, cells expressing the mutant, but not the WT FLAG-MCAK, become increasingly multinucleated when tetracycline was removed indicating that 
Addition of a Green Fluorescent Protein-Tag Stabilizes MCAK
The toxicity of the 628A/629A double mutant could have resulted from a failure of the cell to degrade the mutant protein, or from other structural or functional problems arising from the amino acid substitutions. To distinguish between these possibilities, we compared the accumulation of the AA mutant with WT, the DD mutant, and a green fluorescent protein (GFP)-tagged version of WT MCAK (Supporting Information Fig. S2 ). As expected, the stabilized AA mutant protein, but not the WT or the destabilized DD mutant protein, accumulated over time. Unexpectedly, we found that GFP-MCAK also accumulated over time indicating that the addition of a large Nterminal tag is able to stabilize the protein. Like the AA mutant, and in contrast to FLAG-MCAK, GFP-MCAK also interfered with cell division (Fig. 5) . The simple conclusion from these observations is that stabilization of MCAK is toxic to the cell because it accumulates to unacceptable levels. This conclusion is consistent with previous studies showing that low expression (two to four times the endogenous MCAK level) of FLAG-MCAK is well tolerated, but six-to eightfold overexpression is toxic to CHO cells [Ganguly et al., 2011a] . However, the AA mutant appeared to exhibit toxicity beyond its ability to accumulate (compare the degree of multinucleation in cells expressing 1.5Â AA mutant vs. 3Â GFP-MCAK in Fig. 5 ). Like the AA mutant, we were also not able to obtain stable clones of the DD mutant and the transiently transfected cells rapidly lost expression, indicating that modification of S628/S629 to inhibit or mimic phosphorylation produces toxic effects irrespective of their effects on protein stability. Together, these observations suggest that phosphorylation of the 628/629 sites may have direct effects on MCAK function.
To determine whether GFP was able to stabilize MCAK because it interfered with phosphorylation of S628/S629, cells were synchronized by successive thymidine and nocodazole blocks, and mitotic cell lysates were examined on Western blots using an antibody to MCAK (Fig. 6) . The results revealed a slower migrating form of GFP-MCAK that appeared during prometaphase and persisted through telophase and into the next cell cycle, indicating that the presence of GFP at the N-terminus did not prevent phosphorylation of residues S628/S629. Moreover, the extent of phosphorylation of GFP-MCAK Stably transfected cell lines able to produce four times (Â4) the normal MCAK levels for FLAG-MCAK, Â3 for GFP-MCAK, and Â1.5 for AA FLAG-MCAK (all measured after 16 h of expression) were induced by removing tetracycline, fixed at varying times after induction, stained with DAPI and an antibody to MCAK, and viewed by immunofluorescence. The percentage of cells that were multinucleated (i.e., had micronuclei, multinuclei, or larger than diploid nuclei) at each time point are plotted. At least 300 cells were counted at each time point and the experiment was repeated three times. Averages with their corresponding standard deviations are shown.
n 306 appeared to be similar to FLAG-MCAK in prometaphase cells blocked in nocodazole (Fig. 2 and see [Ganguly et al., 2008] , Fig. 3A, lane 5) . GFP-MCAK thus provides a good control for discriminating between the effects of MCAK stabilization and other changes that may result from blocking the phosphorylation of MCAK.
Phosphorylation of S628/S629 Is Required to Release FLAG-MCAK from Centromeres
To determine why the AA mutant might be causing mitotic defects at low expression levels, we examined its localization. We previously reported that FLAG-MCAK is found at the same sites as the endogenous protein [Ganguly et al., 2008] . During interphase it was found associated with centrosomes, diffusely localized in the cytoplasm and nucleus, and weakly associated with cellular microtubules. When cells entered prophase, there was a dramatic reorganization of the FLAG-MCAK to mitotic centromeres and spindle poles as well as continued diffuse cytoplasmic and weak spindle microtubule localization. FLAG-MCAK fluorescence remained strong during prometaphase but was greatly reduced once the cells progressed beyond metaphase. Centromere staining continued to be weak during anaphase and telophase (Fig. 7) .
The AA mutant protein displayed a similar localization pattern during the early stages of mitosis, but did not disappear following metaphase and, strikingly, remained associated with centromeres even in interphase cells (Fig. 7) . In contrast to the AA mutant, the DD mutant produced a staining pattern similar to the WT protein, indicating that mutation of the 628/629 site per se was insufficient to cause retention of the protein on centromeres. We therefore reasoned that the continued presence of the AA mutant FLAG-MCAK on the centromeres during interphase might have simply resulted from its failure to be degraded, or from an inability of the phosphorylation-resistant protein to be released. To distinguish between these possibilities, we examined the localization of GFP-MCAK and found that it also remained attached to centromeres during anaphase and telophase indicating that simply stabilizing the protein was at least partially responsible for its continued binding during the latter stages of mitosis. However, in contrast to the AA mutant, GFP-MCAK was absent from centromeres during interphase (Fig. 7) . Our tentative conclusion from these observations is that phosphorylation of S628/S629 is not only required for degradation of MCAK, but it may also be required to release MCAK from centromeres.
Phosphorylation of S628 Occurs During Prometaphase
The binding of MCAK to centromeres occurs during prophase and has been shown to require phosphorylation by Aurora B kinase [Andrews et al., 2004; Lan et al., 2004] . Because degradation of the protein predominantly occurs at the metaphase/anaphase transition and is not dependent on Aurora B, we reasoned that phosphorylation of S628 should occur later in mitosis. To test this possibility, we synchronized CHO cells and used a shake-off procedure to isolate mitotic cells. DNA staining revealed that the cells remaining on the dish were $ 70% in prophase with the remainder in interphase, whereas the cells that were removed from the dish by shaking were predominantly (85-90%) in prometaphase. SDS gel electrophoresis of the cell lysates (Fig. 8) showed that an upper (S628 phosphorylated) band was not detected in the prophase cells (lane 1), but was prominent in the prometaphase population (lane 2). By the time the cells reached telophase (lane 3), both bands were missing consistent with degradation of the protein at the metaphase to anaphase transition. The results support a model in which phosphorylation by Aurora B occurs early in mitosis to target MCAK to centromeres, and phosphorylation of S628 occurs later in mitosis to allow removal of MCAK from centromeres and target it for degradation.
Discussion
MCAK plays important roles in spindle assembly and function. Its location at mitotic centromeres and kinetochores has been linked to the correction of inappropriate microtubule attachments that would otherwise lead to missegregation of chromosomes . At spindle poles, the presence of MCAK-like proteins in Drosophila has been implicated in the depolymerization of spindle microtubules to produce a flux of tubulin subunits involved in the poleward movement of sister chromatids [Rogers et al., 2004] . More recently, MCAK has been shown to catalyze the detachment of microtubules from spindle poles and to mediate the effects of tubulin binding drugs on cell division [Ganguly et al., 2011a, b] . The importance of MCAK has been further highlighted by in vitro antibody depletion experiments and in vivo inhibitory RNA studies that resulted in altered spindle morphology as well as an elevated frequency of lagging chromosomes that in turn led to increased cell death or multinucleation [Walczak et al., 1996; KlineSmith and Walczak, 2002; Kline-Smith et al., 2004; Ganguly et al., 2011b] . Overexpression of MCAK has similarly been shown to cause defects in cell division that lead to cell death or multinucleation [Kline-Smith and Walczak, 2002; Holmfeldt et al., 2004; Ganguly et al., 2011a] . The isolation of multiple stably transfected cell lines with tetracycline regulated expression has further shown that small increases in MCAK production (two-to fourfold) are well tolerated, but six-to eightfold overexpression is toxic [Ganguly et al., 2011a] . It is thus critical that cells be able to regulate their levels of MCAK and the way this has been accomplished is to synthesize and accumulate new protein during each cell cycle and then degrade it during mitosis [Ganguly et al., 2008] .
The current studies demonstrate that the degradation of MCAK is controlled by phosphorylation of residues S628/ S629. Although mutation of both residues was necessary to fully stabilize the protein due to secondary phosphorylation of S629 when residue S628 is mutated, phosphorylation of S628 alone is probably sufficient to trigger degradation because S629 phosphorylation was not detected in the WT protein by MS analysis. The possibility that the S628A/S629A double mutant was stabilized because of changes in structure rather than because phosphorylation was inhibited is unlikely because a S628D/ S629D phosphomimetic mutant was degraded even more efficiently than the WT protein.
The identified phosphorylation site shares homology among mammalian, avian, and amphibian species (Supporting Information Fig. S1 ) but the homology doesn't extend to Leishmania LmjKIN13-1, an MCAK-like protein that also undergoes cell cycle dependent degradation [Dubessay et al., 2006] . Thus, the phosphorylation site appears to be conserved among vertebrates, but it may Fig. 8 . Phosphorylation of S628 during mitosis. Cells expressing WT FLAG-MCAK were synchronized using an overnight thymidine block. Tetracycline was then added during the following steps to prevent further transcription of the cDNA. The cells were reversed from thymidine for 4 h followed by nocodazole treatment. When the majority of cells reached mitosis, mitotic cells were shaken off and released from the nocodazole block. Proteins were analyzed on Western blots with antibodies to FLAG and actin (as a loading control). Lane 1, cells remaining on the dish after the mitotic shake-off. Approximately 70% of these cells were in prophase. Lane 2, cells in nocodazole. Greater than 90% of the cells were in prometaphase. Lane 3, 30 min after reversal of the nocodazole block. The majority of the cells were in telophase or early G1. Note the presence of a slower migrating band during prometaphase indicating phosphorylation at S628, and the absence of MCAK in cells that reached telophase.
n 308 Ganguly et al. have diverged considerably from the site used by lower organisms. A scan of databases using the sequence around S628 did not reveal a clear consensus for any kinase, and our initial use of inhibitors to identify the kinase responsible for phosphorylation have thus far been unsuccessful. Similarly, MCAK does not have obvious D-box, KENbox, or other consensus sites for destruction [Glotzer et al., 1991; Pfleger and Kirschner, 2000; Song and Rape, 2011] and so the sequence that serves as the actual degradation signal is not yet known. S628/S629 is located in the C-terminal region of MCAK, an area that has been implicated in dimerization [Maney et al., 2001; EmsMcClung et al., 2007] , but there is no evidence that mutation of this site produces any changes in the quaternary structure of the protein. On the other hand, there is considerable evidence from domain mapping studies to suggest that the C-terminal region is able to interact functionally, and perhaps physically, with the N-terminal or neck region of the protein [Ems-McClung et al., 2007] . This view is consistent with our observation that addition of GFP to the N-terminus is able to stabilize the protein even though it doesn't appear to affect phosphorylation of S628/S629. The ability of changes in the N-terminus as well as C-terminal region to affect the stability of the protein suggests the possibility that phosphorylation of the S628/S629 site might act by altering N-C interactions.
Production of the AA mutant proved to be toxic. Stable clones were difficult to isolate and cells rapidly lost expression of the cDNA even though its transcription was under tetracycline regulation, suggesting that even the small amount of mutant production resulting from leakiness of the tetracycline block was enough to cause toxicity. Part of this toxicity likely resulted from the accumulation of the mutant protein to unacceptable levels as evidenced by the observation that a GFP-tagged version of the WT protein also was stabilized, accumulated with time, and exhibited toxicity. However, the observation that delayed mitotic progression and defective cytokinesis (as indicated by the presence of multinucleated cells) was evident with low production and at early times after induction of the AA mutant suggests that the AA mutations may also be able to more directly interfere with the function of the protein.
It thus appeared that failure to degrade MCAK could cause eventual toxicity because of protein accumulation, but that the failure to phosphorylate the AA mutant was causing more immediate problems.
A potential cause for the enhanced toxicity of the AA mutant compared to the stabilized GFP-MCAK may be traced to its ability to remain associated with mitotic centromeres throughout the cell cycle. As summarized in Fig.  9 , newly synthesized AA mutant (green) does not bind to centromeres until cells enter mitosis, whereupon it is phosphorylated by Aurora B kinase and competes with endogenous phosphorylated WT MCAK (red) for binding to centromeres (colored yellow to indicate the presence of both WT and AA mutant). Following metaphase, the WT protein is released and degraded, but the AA mutant persists at centromeres (now colored green) and remains attached throughout the cell cycle and into the next mitosis. We speculate that ''old'' AA mutant protein carried over from the previous mitosis may interfere more strongly with spindle assembly and function because there is now more mutant protein relative to WT protein, the presence of the AA mutant at the centromere may prevent the binding of newly synthesized MCAK, and the ''old'' AA mutant protein may retain some of the phosphorylations that were carried out during the previous mitosis. The presence of such modified AA mutant might then interfere with the regulation that normally takes place during mitotic progression, a situation that doesn't occur with WT MCAK because of Fig. 9 . Model showing the effects of the S628A/S629A mutations on MCAK function. After the induction of the AA mutant, cells enter the first mitosis (prometaphase 1) with naive endogenous WT (red) and ectopic AA mutant (green) proteins that require Aurora B kinase phosphorylation before they can bind to centromeres (yellow to show the presence of both endogenous and AA mutant). Once cells attain a stable metaphase configuration, the WT protein is degraded because it is phosphorylated on residue 628 leaving only the AA mutant protein on centromeres. The AA mutant protein persists through anaphase, telophase, and into the next cell cycle where it, but not the newly synthesized WT protein, remains bound to centromeres. Diffuse staining is also seen for both WT and mutant proteins (light yellow color). As cells enter the next mitosis (prometaphase 2), the amount of mutant protein is higher relative to the WT protein because of its failure to be degraded during the previous mitosis. We propose that toxicity results from the increased total amount of MCAK as well as the centromeric localization of modified AA mutant protein carried over from the previous cell cycle that may disrupt the binding of newly synthesized naive MCAK and interfere with the phosphorylations that normally regulate MCAK activity during mitosis.
its degradation after metaphase. This scenario does not rule out the possibility that there may also be other more direct effects on MCAK function caused by preventing the phosphorylation of S628/S629.
In summary, we identified a phosphorylation site that controls the cell cycle degradation of MCAK and demonstrated that failure to phosphorylate this site stabilizes the protein and prevents its removal from centromeres. We further showed that adding GFP to the N-terminus of MCAK also stabilizes the protein and causes eventual toxicity without inhibiting thephosphorylation of S628/S629 and without preventing the removal of the protein from centromeres. The results demonstrate the importance of cell cycle degradation of MCAK and suggest that phosphorylation of the site that controls degradation may also regulate the removal of MCAK from centromeres.
Materials and Methods
Cell Lines and Antibodies
Chinese hamster ovary (CHO) cells [Cabral et al., 1980] were maintained in alpha modification of minimal essential medium (Mediatech Inc., Manassas, VA) supplemented with 5% fetal bovine serum (Gemini Bio-Products, West Sacramento, CA). Mouse Flag-M2 and DM1a antibodies were purchased from Sigma-Aldrich (St. Louis, MO), MCAK polyclonal antibody came from Cytoskeleton, Inc. (Denver, CO), and actin antibody C4 was from Millipore (Billerica, MA). All Alexa-conjugated secondary antibodies came from Invitrogen (Carlsbad, CA). Chemicals were from Sigma-Aldrich unless otherwise stated.
Cell Synchronization CHO cells were synchronized by incubating them overnight in medium containing 5 mM thymidine, reversing the S-phase block for 4 h, adding 35 ng/ml nocodazole for $ 3 h, and shaking off mitotic cells as previously described [Ganguly et al., 2008] . Cell cycle blockage was confirmed using a flow cytometer (Guava Technologies, Hayward, CA) and also by staining a small aliquot of the cells with 2 lg/ml HOECHST 33342 and observing the chromosome organization by fluorescence microscopy. More than 90% of the mitotic shake-off cells were typically found to be in prometaphase.
Immunoprecipitation and Mass Spectrometry
A stable CHO cell line expressing eight times the endogenous level of FLAG-MCAK was synchronized in prometaphase, lysed in microtubule buffer [20 mM Tris-HCl, pH 6.8, 0.5% Nonidet P-40, 1 mM MgCl 2 , 2 mM ethylene glycol tetraacetic acid (EGTA) and 140 mM NaCl], and centrifuged at 12,000 Â g for 15 min at 4 C to remove cellular debris. The supernatant was then incubated for 14 h at 4 C with anti-FLAG antibodies (M2, Sigma) that were immobilized on Protein G agarose beads, the immunoprecipitate was dissolved in SDS sample buffer, and the proteins were resolved on a 7.5% polyacrylamide gel. Coomassie blue staining revealed two closely spaced major bands having a mobility consistent with MCAK. Each band was separately excised and sent for phosphopeptide mapping by mass spectrometry (MS) (Center for Functional Genomics, University at Albany, Rensselaer, NY). The gel pieces were washed, reduced, alkylated, and digested with trypsin. Peptides extracted from the gel were enriched for phosphopeptides using a TiO 2 column and then concentrated and dissolved in 5% formic acid for liquid chromatography (LS)-MS/MS using a CapLC and Q-Tof2 (both from Waters Co., Milford, MA). Files containing mass and intensity values were generated using Masslynx 3.5 software (Waters). MASCOT 2.2 (Matrix Science, London, UK) was used to compare the data to the sequence of MCAK.
Site Directed Mutagenesis
Human MCAK cDNA (GenBank Accession No. BC014924) was obtained from the American Type Culture Collection and cloned into the tetracycline-regulated mammalian expression vector, pTOPneo [Gonzalez-Garay et al., 1999; Ganguly et al., 2008] . The MCAK cDNA also contained a FLAG epitope tag at the 5 0 -end for convenient detection of the protein. Site-directed mutagenesis was carried out with the QuickChange mutagenesis kit (Invitrogen) and all mutations were confirmed by sequencing.
Isolation of Stably Transfected Cell Lines
CHO tTA6.6a cells expressing a tetracycline-regulated transactivator [Gonzalez-Garay et al., 1999] were seeded into 35-mm tissue culture dishes and transfected with wild-type (WT) or mutant pTOP/FLAG-MCAK using Lipofectamine (Invitrogen). Following transfection, the cells were grown overnight in the presence of 1 lg/ml tetracycline, then trypsinized and replated in 100-mm dishes containing growth medium, 1 lg/ml tetracycline, and 2 mg/ml G418. After 10 days the drug resistant cells were trypsinized and stored as a total G418-resistant population. From the stable G418 population about 100 cells were plated on 60 mm dishes in tetracycline and G418 and incubated 7-10 days until they formed visible colonies. The colonies were isolated and screened by Western blot analysis for FLAG-MCAK production. Cell lines with low production (<4 times endogenous MCAK) were chosen for further studies.
Immunofluorescence
Cells grown on glass coverslips were pre-extracted for 1 min at 4 C with microtubule buffer containing 4 lg/ml paclitaxel and then fixed in methanol at À20 C for 20 min. The n 310 fixed cells were stained with a 1:50 dilution of mouse FLAG-specific antibody M2 followed by goat antimouse IgG conjugated to Alexa 488 at a 1:100 dilution. The secondary antibody solution also contained 1 lg/ml 4 0 -6-diamidino-2-phenylindole (DAPI) to stain chromosomes.
Electrophoretic Techniques
Cells were lysed in 1% SDS, and the proteins were precipitated with five volumes of ice-cold acetone and then pelleted at 12,000 Â g for 5 min. The pellet was solubilized in SDS sample buffer (0.0625 M Tris-HCl, pH 6.8, 2.5% SDS, 5% 2-mercaptoethanol, 10% glycerol), fractionated on 7.5% polyacrylamide SDS minigels, and transferred to a nitrocellulose membrane. The membranes were then blocked in 2% milk in phosphate buffered saline containing 0.05% Tween-20 (PBST) for 1 h, washed three times in PBST, and incubated in 1:2000 dilutions of rabbit anti-MCAK or mouse anti-FLAG M2 antibody. A 1:30,000 dilution of actin antibody C4 or a 1:4000 dilution of tubulin antibody DM1A was also added as a control for sample loading. Antibody incubations were carried out for 2 h at room temperature. Reactive bands were detected with 1:2000 dilutions of Alexa 647-conjugated goat anti-mouse and anti-rabbit IgGs and visualized with a STORM 860 imager (Molecular Dynamics, Sunnyvale, CA).
